Global Poliomyelitis Vaccine Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Poliomyelitis Vaccine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Poliomyelitis Vaccine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Poliomyelitis Vaccine by Country/Region, 2017, 2022 & 2028

2.2 Poliomyelitis Vaccine Segment by Type

2.2.1 Poliomyelitis Vaccine �

�

2.2.2 Poliomyelitis Vaccine �

�

2.2.3 Poliomyelitis Vaccine �

�

2.2.4 Oral Poliomyelitis Vaccine

2.3 Poliomyelitis Vaccine Sales by Type

2.3.1 Global Poliomyelitis Vaccine Sales Market Share by Type (2017-2022)

2.3.2 Global Poliomyelitis Vaccine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Poliomyelitis Vaccine Sale Price by Type (2017-2022)

2.4 Poliomyelitis Vaccine Segment by Application

2.4.1 VAPP

2.4.2 VDPV

2.5 Poliomyelitis Vaccine Sales by Application

2.5.1 Global Poliomyelitis Vaccine Sale Market Share by Application (2017-2022)

2.5.2 Global Poliomyelitis Vaccine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Poliomyelitis Vaccine Sale Price by Application (2017-2022)

3 Global Poliomyelitis Vaccine by Company

3.1 Global Poliomyelitis Vaccine Breakdown Data by Company

3.1.1 Global Poliomyelitis Vaccine Annual Sales by Company (2020-2022)

3.1.2 Global Poliomyelitis Vaccine Sales Market Share by Company (2020-2022)

3.2 Global Poliomyelitis Vaccine Annual Revenue by Company (2020-2022)

3.2.1 Global Poliomyelitis Vaccine Revenue by Company (2020-2022)

3.2.2 Global Poliomyelitis Vaccine Revenue Market Share by Company (2020-2022)

3.3 Global Poliomyelitis Vaccine Sale Price by Company

3.4 Key Manufacturers Poliomyelitis Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Poliomyelitis Vaccine Product Location Distribution

3.4.2 Players Poliomyelitis Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Poliomyelitis Vaccine by Geographic Region

4.1 World Historic Poliomyelitis Vaccine Market Size by Geographic Region (2017-2022)

4.1.1 Global Poliomyelitis Vaccine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Poliomyelitis Vaccine Annual Revenue by Geographic Region

4.2 World Historic Poliomyelitis Vaccine Market Size by Country/Region (2017-2022)

4.2.1 Global Poliomyelitis Vaccine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Poliomyelitis Vaccine Annual Revenue by Country/Region

4.3 Americas Poliomyelitis Vaccine Sales Growth

4.4 APAC Poliomyelitis Vaccine Sales Growth

4.5 Europe Poliomyelitis Vaccine Sales Growth

4.6 Middle East & Africa Poliomyelitis Vaccine Sales Growth

5 Americas

5.1 Americas Poliomyelitis Vaccine Sales by Country

5.1.1 Americas Poliomyelitis Vaccine Sales by Country (2017-2022)

5.1.2 Americas Poliomyelitis Vaccine Revenue by Country (2017-2022)

5.2 Americas Poliomyelitis Vaccine Sales by Type

5.3 Americas Poliomyelitis Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Poliomyelitis Vaccine Sales by Region

6.1.1 APAC Poliomyelitis Vaccine Sales by Region (2017-2022)

6.1.2 APAC Poliomyelitis Vaccine Revenue by Region (2017-2022)

6.2 APAC Poliomyelitis Vaccine Sales by Type

6.3 APAC Poliomyelitis Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Poliomyelitis Vaccine by Country

7.1.1 Europe Poliomyelitis Vaccine Sales by Country (2017-2022)

7.1.2 Europe Poliomyelitis Vaccine Revenue by Country (2017-2022)

7.2 Europe Poliomyelitis Vaccine Sales by Type

7.3 Europe Poliomyelitis Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Poliomyelitis Vaccine by Country

8.1.1 Middle East & Africa Poliomyelitis Vaccine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Poliomyelitis Vaccine Revenue by Country (2017-2022)

8.2 Middle East & Africa Poliomyelitis Vaccine Sales by Type

8.3 Middle East & Africa Poliomyelitis Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Poliomyelitis Vaccine

10.3 Manufacturing Process Analysis of Poliomyelitis Vaccine

10.4 Industry Chain Structure of Poliomyelitis Vaccine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Poliomyelitis Vaccine Distributors

11.3 Poliomyelitis Vaccine Customer

12 World Forecast Review for Poliomyelitis Vaccine by Geographic Region

12.1 Global Poliomyelitis Vaccine Market Size Forecast by Region

12.1.1 Global Poliomyelitis Vaccine Forecast by Region (2023-2028)

12.1.2 Global Poliomyelitis Vaccine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Poliomyelitis Vaccine Forecast by Type

12.7 Global Poliomyelitis Vaccine Forecast by Application

13 Key Players Analysis

13.1 GSK

13.1.1 GSK Company Information

13.1.2 GSK Poliomyelitis Vaccine Product Offered

13.1.3 GSK Poliomyelitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 GSK Main Business Overview

13.1.5 GSK Latest Developments

13.2 Sanofi-Pasteur

13.2.1 Sanofi-Pasteur Company Information

13.2.2 Sanofi-Pasteur Poliomyelitis Vaccine Product Offered

13.2.3 Sanofi-Pasteur Poliomyelitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Sanofi-Pasteur Main Business Overview

13.2.5 Sanofi-Pasteur Latest Developments

13.3 Merck

13.3.1 Merck Company Information

13.3.2 Merck Poliomyelitis Vaccine Product Offered

13.3.3 Merck Poliomyelitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Merck Main Business Overview

13.3.5 Merck Latest Developments

13.4 Crucell

13.4.1 Crucell Company Information

13.4.2 Crucell Poliomyelitis Vaccine Product Offered

13.4.3 Crucell Poliomyelitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Crucell Main Business Overview

13.4.5 Crucell Latest Developments

13.5 China National Biotech Group

13.5.1 China National Biotech Group Company Information

13.5.2 China National Biotech Group Poliomyelitis Vaccine Product Offered

13.5.3 China National Biotech Group Poliomyelitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 China National Biotech Group Main Business Overview

13.5.5 China National Biotech Group Latest Developments

13.6 Eli Lilly

13.6.1 Eli Lilly Company Information

13.6.2 Eli Lilly Poliomyelitis Vaccine Product Offered

13.6.3 Eli Lilly Poliomyelitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Eli Lilly Main Business Overview

13.6.5 Eli Lilly Latest Developments

14 Research Findings and Conclusion

Table 1. Poliomyelitis Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Poliomyelitis Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Poliomyelitis Vaccine �

�

Table 4. Major Players of Poliomyelitis Vaccine �

�

Table 5. Major Players of Poliomyelitis Vaccine �

�

Table 6. Major Players of Oral Poliomyelitis Vaccine

Table 7. Global Poliomyelitis Vaccine Sales by Type (2017-2022) & (K Units)

Table 8. Global Poliomyelitis Vaccine Sales Market Share by Type (2017-2022)

Table 9. Global Poliomyelitis Vaccine Revenue by Type (2017-2022) & ($ million)

Table 10. Global Poliomyelitis Vaccine Revenue Market Share by Type (2017-2022)

Table 11. Global Poliomyelitis Vaccine Sale Price by Type (2017-2022) & (USD/Unit)

Table 12. Global Poliomyelitis Vaccine Sales by Application (2017-2022) & (K Units)

Table 13. Global Poliomyelitis Vaccine Sales Market Share by Application (2017-2022)

Table 14. Global Poliomyelitis Vaccine Revenue by Application (2017-2022)

Table 15. Global Poliomyelitis Vaccine Revenue Market Share by Application (2017-2022)

Table 16. Global Poliomyelitis Vaccine Sale Price by Application (2017-2022) & (USD/Unit)

Table 17. Global Poliomyelitis Vaccine Sales by Company (2020-2022) & (K Units)

Table 18. Global Poliomyelitis Vaccine Sales Market Share by Company (2020-2022)

Table 19. Global Poliomyelitis Vaccine Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Poliomyelitis Vaccine Revenue Market Share by Company (2020-2022)

Table 21. Global Poliomyelitis Vaccine Sale Price by Company (2020-2022) & (USD/Unit)

Table 22. Key Manufacturers Poliomyelitis Vaccine Producing Area Distribution and Sales Area

Table 23. Players Poliomyelitis Vaccine Products Offered

Table 24. Poliomyelitis Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Poliomyelitis Vaccine Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global Poliomyelitis Vaccine Sales Market Share Geographic Region (2017-2022)

Table 29. Global Poliomyelitis Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Poliomyelitis Vaccine Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Poliomyelitis Vaccine Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global Poliomyelitis Vaccine Sales Market Share by Country/Region (2017-2022)

Table 33. Global Poliomyelitis Vaccine Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Poliomyelitis Vaccine Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Poliomyelitis Vaccine Sales by Country (2017-2022) & (K Units)

Table 36. Americas Poliomyelitis Vaccine Sales Market Share by Country (2017-2022)

Table 37. Americas Poliomyelitis Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Poliomyelitis Vaccine Revenue Market Share by Country (2017-2022)

Table 39. Americas Poliomyelitis Vaccine Sales by Type (2017-2022) & (K Units)

Table 40. Americas Poliomyelitis Vaccine Sales Market Share by Type (2017-2022)

Table 41. Americas Poliomyelitis Vaccine Sales by Application (2017-2022) & (K Units)

Table 42. Americas Poliomyelitis Vaccine Sales Market Share by Application (2017-2022)

Table 43. APAC Poliomyelitis Vaccine Sales by Region (2017-2022) & (K Units)

Table 44. APAC Poliomyelitis Vaccine Sales Market Share by Region (2017-2022)

Table 45. APAC Poliomyelitis Vaccine Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Poliomyelitis Vaccine Revenue Market Share by Region (2017-2022)

Table 47. APAC Poliomyelitis Vaccine Sales by Type (2017-2022) & (K Units)

Table 48. APAC Poliomyelitis Vaccine Sales Market Share by Type (2017-2022)

Table 49. APAC Poliomyelitis Vaccine Sales by Application (2017-2022) & (K Units)

Table 50. APAC Poliomyelitis Vaccine Sales Market Share by Application (2017-2022)

Table 51. Europe Poliomyelitis Vaccine Sales by Country (2017-2022) & (K Units)

Table 52. Europe Poliomyelitis Vaccine Sales Market Share by Country (2017-2022)

Table 53. Europe Poliomyelitis Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Poliomyelitis Vaccine Revenue Market Share by Country (2017-2022)

Table 55. Europe Poliomyelitis Vaccine Sales by Type (2017-2022) & (K Units)

Table 56. Europe Poliomyelitis Vaccine Sales Market Share by Type (2017-2022)

Table 57. Europe Poliomyelitis Vaccine Sales by Application (2017-2022) & (K Units)

Table 58. Europe Poliomyelitis Vaccine Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Poliomyelitis Vaccine Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa Poliomyelitis Vaccine Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Poliomyelitis Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Poliomyelitis Vaccine Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Poliomyelitis Vaccine Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa Poliomyelitis Vaccine Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Poliomyelitis Vaccine Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa Poliomyelitis Vaccine Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Poliomyelitis Vaccine

Table 68. Key Market Challenges & Risks of Poliomyelitis Vaccine

Table 69. Key Industry Trends of Poliomyelitis Vaccine

Table 70. Poliomyelitis Vaccine Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Poliomyelitis Vaccine Distributors List

Table 73. Poliomyelitis Vaccine Customer List

Table 74. Global Poliomyelitis Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global Poliomyelitis Vaccine Sales Market Forecast by Region

Table 76. Global Poliomyelitis Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Poliomyelitis Vaccine Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Poliomyelitis Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas Poliomyelitis Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Poliomyelitis Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC Poliomyelitis Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Poliomyelitis Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe Poliomyelitis Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Poliomyelitis Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa Poliomyelitis Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Poliomyelitis Vaccine Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global Poliomyelitis Vaccine Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Poliomyelitis Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Poliomyelitis Vaccine Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Poliomyelitis Vaccine Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global Poliomyelitis Vaccine Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Poliomyelitis Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Poliomyelitis Vaccine Revenue Market Share Forecast by Application (2023-2028)

Table 94. GSK Basic Information, Poliomyelitis Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 95. GSK Poliomyelitis Vaccine Product Offered

Table 96. GSK Poliomyelitis Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 97. GSK Main Business

Table 98. GSK Latest Developments

Table 99. Sanofi-Pasteur Basic Information, Poliomyelitis Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 100. Sanofi-Pasteur Poliomyelitis Vaccine Product Offered

Table 101. Sanofi-Pasteur Poliomyelitis Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 102. Sanofi-Pasteur Main Business

Table 103. Sanofi-Pasteur Latest Developments

Table 104. Merck Basic Information, Poliomyelitis Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 105. Merck Poliomyelitis Vaccine Product Offered

Table 106. Merck Poliomyelitis Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 107. Merck Main Business

Table 108. Merck Latest Developments

Table 109. Crucell Basic Information, Poliomyelitis Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 110. Crucell Poliomyelitis Vaccine Product Offered

Table 111. Crucell Poliomyelitis Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 112. Crucell Main Business

Table 113. Crucell Latest Developments

Table 114. China National Biotech Group Basic Information, Poliomyelitis Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 115. China National Biotech Group Poliomyelitis Vaccine Product Offered

Table 116. China National Biotech Group Poliomyelitis Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 117. China National Biotech Group Main Business

Table 118. China National Biotech Group Latest Developments

Table 119. Eli Lilly Basic Information, Poliomyelitis Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 120. Eli Lilly Poliomyelitis Vaccine Product Offered

Table 121. Eli Lilly Poliomyelitis Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 122. Eli Lilly Main Business

Table 123. Eli Lilly Latest Developments

List of Figures

Figure 1. Picture of Poliomyelitis Vaccine

Figure 2. Poliomyelitis Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Poliomyelitis Vaccine Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Poliomyelitis Vaccine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Poliomyelitis Vaccine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Poliomyelitis Vaccine �

�

Figure 10. Product Picture of Poliomyelitis Vaccine �

�

Figure 11. Product Picture of Poliomyelitis Vaccine �

�

Figure 12. Product Picture of Oral Poliomyelitis Vaccine

Figure 13. Global Poliomyelitis Vaccine Sales Market Share by Type in 2021

Figure 14. Global Poliomyelitis Vaccine Revenue Market Share by Type (2017-2022)

Figure 15. Poliomyelitis Vaccine Consumed in VAPP

Figure 16. Global Poliomyelitis Vaccine Market: VAPP (2017-2022) & (K Units)

Figure 17. Poliomyelitis Vaccine Consumed in VDPV

Figure 18. Global Poliomyelitis Vaccine Market: VDPV (2017-2022) & (K Units)

Figure 19. Global Poliomyelitis Vaccine Sales Market Share by Application (2017-2022)

Figure 20. Global Poliomyelitis Vaccine Revenue Market Share by Application in 2021

Figure 21. Poliomyelitis Vaccine Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Poliomyelitis Vaccine Revenue Market Share by Company in 2021

Figure 23. Global Poliomyelitis Vaccine Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Poliomyelitis Vaccine Revenue Market Share by Geographic Region in 2021

Figure 25. Global Poliomyelitis Vaccine Sales Market Share by Region (2017-2022)

Figure 26. Global Poliomyelitis Vaccine Revenue Market Share by Country/Region in 2021

Figure 27. Americas Poliomyelitis Vaccine Sales 2017-2022 (K Units)

Figure 28. Americas Poliomyelitis Vaccine Revenue 2017-2022 ($ Millions)

Figure 29. APAC Poliomyelitis Vaccine Sales 2017-2022 (K Units)

Figure 30. APAC Poliomyelitis Vaccine Revenue 2017-2022 ($ Millions)

Figure 31. Europe Poliomyelitis Vaccine Sales 2017-2022 (K Units)

Figure 32. Europe Poliomyelitis Vaccine Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Poliomyelitis Vaccine Sales 2017-2022 (K Units)

Figure 34. Middle East & Africa Poliomyelitis Vaccine Revenue 2017-2022 ($ Millions)

Figure 35. Americas Poliomyelitis Vaccine Sales Market Share by Country in 2021

Figure 36. Americas Poliomyelitis Vaccine Revenue Market Share by Country in 2021

Figure 37. United States Poliomyelitis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Poliomyelitis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Poliomyelitis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Poliomyelitis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Poliomyelitis Vaccine Sales Market Share by Region in 2021

Figure 42. APAC Poliomyelitis Vaccine Revenue Market Share by Regions in 2021

Figure 43. China Poliomyelitis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Poliomyelitis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Poliomyelitis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Poliomyelitis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Poliomyelitis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Poliomyelitis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Poliomyelitis Vaccine Sales Market Share by Country in 2021

Figure 50. Europe Poliomyelitis Vaccine Revenue Market Share by Country in 2021

Figure 51. Germany Poliomyelitis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Poliomyelitis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Poliomyelitis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Poliomyelitis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Poliomyelitis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Poliomyelitis Vaccine Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Poliomyelitis Vaccine Revenue Market Share by Country in 2021

Figure 58. Egypt Poliomyelitis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Poliomyelitis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Poliomyelitis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Poliomyelitis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Poliomyelitis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Poliomyelitis Vaccine in 2021

Figure 64. Manufacturing Process Analysis of Poliomyelitis Vaccine

Figure 65. Industry Chain Structure of Poliomyelitis Vaccine

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles